磁共振成像-超声融合引导下的前列腺活检：技术、操作方法及结果综述
Magnetic Resonance Imaging-Ultrasound Fusion-Guided Prostate Biopsy: Review of Technology, Techniques, and Outcomes.
作者信息
Kongnyuy Michael, George Arvin K, Rastinehad Ardeshir R, Pinto Peter A
机构信息
Urologic Oncology Branch, National Institutes of Health, National Cancer Institute, 10 Center Drive, Bethesda, MD, 20814, USA.
Icahn School of Medicine at Mount Sinai, 625 Madison Avenue, New York, NY, USA.
出版信息
Curr Urol Rep. 2016 Apr;17(4):32. doi: 10.1007/s11934-016-0589-z.
Abstract
Transrectal ultrasound (TRUS)-guided (12-14 core) systematic biopsy of the prostate is the recommended standard for patients with suspicion of prostate cancer (PCa). Advances in imaging have led to the application of magnetic resonance imaging (MRI) for the detection of PCa with subsequent development of software-based co-registration allowing for the integration of MRI with real-time TRUS during prostate biopsy. A number of fusion-guided methods and platforms are now commercially available with common elements in image and analysis and planning. Implementation of fusion-guided prostate biopsy has now been proven to improve the detection of clinically significant PCa in appropriately selected patients.
摘要
经直肠超声（TRUS）引导下（12 - 14针芯）的前列腺系统活检是疑似前列腺癌（PCa）患者的推荐标准方法。成像技术的进步促使磁共振成像（MRI）应用于PCa检测，随后基于软件的共配准技术得以发展，使得在前列腺活检过程中MRI能与实时TRUS相结合。现在有多种融合引导方法和平台可供商业使用，它们在图像、分析和规划方面有共同要素。现已证明，在适当选择的患者中实施融合引导的前列腺活检可提高临床显著性PCa的检出率。
相似文献
1
Magnetic Resonance Imaging-Ultrasound Fusion-Guided Prostate Biopsy: Review of Technology, Techniques, and Outcomes.
Curr Urol Rep. 2016 Apr;17(4):32. doi: 10.1007/s11934-016-0589-z.
2
Elastic Versus Rigid Image Registration in Magnetic Resonance Imaging-transrectal Ultrasound Fusion Prostate Biopsy: A Systematic Review and Meta-analysis.
Eur Urol Focus. 2018 Mar;4(2):219-227. doi: 10.1016/j.euf.2016.07.003. Epub 2016 Jul 29.
3
Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies.
Eur Urol. 2015 Oct;68(4):713-20. doi: 10.1016/j.eururo.2015.06.008. Epub 2015 Jun 23.
4
Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial.
Eur Urol. 2016 Mar;69(3):419-25. doi: 10.1016/j.eururo.2015.05.024. Epub 2015 May 29.
5
[Real-time MRI/US fusion-guided biopsy in biopsy-naïve and pre-biopsied patients with suspicion for prostate cancer].
Aktuelle Urol. 2015 Jan;46(1):34-8. doi: 10.1055/s-0034-1395563. Epub 2014 Dec 17.
6
Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results.
World J Urol. 2015 Nov;33(11):1707-14. doi: 10.1007/s00345-015-1525-4. Epub 2015 Mar 14.
7
Is targeted magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy enough for the detection of prostate cancer in patients with PI-RADS ≥3: Results of a prospective, randomized clinical trial.
J Cancer Res Ther. 2020;16(7):1698-1702. doi: 10.4103/jcrt.JCRT_1495_20.
8
Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.
Eur Urol Oncol. 2018 Jun;1(2):109-117. doi: 10.1016/j.euo.2018.02.010. Epub 2018 May 15.
9
Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy.
Eur Urol. 2013 Nov;64(5):713-719. doi: 10.1016/j.eururo.2013.05.059. Epub 2013 Jun 12.
10
Transperineal Versus Transrectal MRI/TRUS Fusion Targeted Biopsy: Detection Rate of Clinically Significant Prostate Cancer.
Clin Genitourin Cancer. 2017 Feb;15(1):e33-e36. doi: 10.1016/j.clgc.2016.07.007. Epub 2016 Jul 21.
引用本文的文献
1
Review of different convolutional neural networks used in segmentation of prostate during fusion biopsy.
Cent European J Urol. 2025;78(1):23-39. doi: 10.5173/ceju.2024.0064. Epub 2025 Mar 21.
2
Introduction of Androgen Receptor Targeting shRNA Inhibits Tumor Growth in Patient-Derived Prostate Cancer Xenografts.
Curr Oncol. 2023 Oct 24;30(11):9437-9447. doi: 10.3390/curroncol30110683.
3
Ultrasound/MRI-targeted biopsy versus saturated trans-rectal ultrasound guided biopsy of prostate in patients with primary negative conventional biopsy and still elevated PSA: a prospective randomized clinical trial.
Am J Clin Exp Urol. 2023 Aug 15;11(4):312-319. eCollection 2023.
4
Molecular basis and therapeutic targets in prostate cancer: A comprehensive review.
Biomol Biomed. 2023 Sep 4;23(5):760-771. doi: 10.17305/bb.2023.8782.
5
Ultrasound Frame-to-Volume Registration via Deep Learning for Interventional Guidance.
IEEE Trans Ultrason Ferroelectr Freq Control. 2023 Sep;70(9):1016-1025. doi: 10.1109/TUFFC.2022.3229903. Epub 2023 Aug 29.
6
Kinematic and mechanical modelling of a novel 4-DOF robotic needle guide for MRI-guided prostate intervention.
Biomed Eng Adv. 2022 Dec;4. doi: 10.1016/j.bea.2022.100036. Epub 2022 May 24.
7
Application of Multiple Ultrasonic Techniques in the Diagnosis of Prostate Cancer.
Front Oncol. 2022 Jun 27;12:905087. doi: 10.3389/fonc.2022.905087. eCollection 2022.
8
Prostate MRI using a rigid two-channel phased-array endorectal coil: comparison with phased array coil acquisition at 3 T.
Cancer Imaging. 2022 Mar 16;22(1):15. doi: 10.1186/s40644-022-00453-7.
9
Systematic biopsy should not be omitted in the era of combined magnetic resonance imaging/ultrasound fusion-guided biopsies of the prostate.
Int Urol Nephrol. 2021 Nov;53(11):2251-2259. doi: 10.1007/s11255-021-02989-2. Epub 2021 Sep 9.
10
Voxel-level Classification of Prostate Cancer on Magnetic Resonance Imaging: Improving Accuracy Using Four-Compartment Restriction Spectrum Imaging.
J Magn Reson Imaging. 2021 Sep;54(3):975-984. doi: 10.1002/jmri.27623. Epub 2021 Mar 31.
本文引用的文献
1
BiopSee - transperineal stereotactic navigated prostate biopsy.
J Contemp Brachytherapy. 2011 Jun;3(2):91-95. doi: 10.5114/jcb.2011.23203. Epub 2011 Jul 6.
2
A Case of In-Bore Transperineal MRI-Guided Prostate Biopsy of a Patient with Ileal Pouch-Anal Anastomosis.
Case Rep Urol. 2015;2015:676930. doi: 10.1155/2015/676930. Epub 2015 Dec 30.
3
Combined Biparametric Prostate Magnetic Resonance Imaging and Prostate-specific Antigen in the Detection of Prostate Cancer: A Validation Study in a Biopsy-naive Patient Population.
Urology. 2016 Feb;88:125-34. doi: 10.1016/j.urology.2015.09.035. Epub 2015 Dec 8.
4
Comparison of Multiparametric MRI Scoring Systems and the Impact on Cancer Detection in Patients Undergoing MR US Fusion Guided Prostate Biopsies.
PLoS One. 2015 Nov 25;10(11):e0143404. doi: 10.1371/journal.pone.0143404. eCollection 2015.
5
Multiparametric magnetic resonance imaging-transrectal ultrasound fusion-assisted biopsy for the diagnosis of local recurrence after radical prostatectomy.
Urol Oncol. 2015 Oct;33(10):425.e1-425.e6. doi: 10.1016/j.urolonc.2015.05.021. Epub 2015 Aug 8.
6
Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging.
Radiology. 2015 Dec;277(3):741-50. doi: 10.1148/radiol.2015142818. Epub 2015 Jun 18.
7
Optimizing Patient Population for MP-MRI and Fusion Biopsy for Prostate Cancer Detection.
Curr Urol Rep. 2015 Jul;16(7):50. doi: 10.1007/s11934-015-0521-y.
8
The role of MRI in active surveillance for prostate cancer.
Curr Urol Rep. 2015 Jun;16(6):42. doi: 10.1007/s11934-015-0507-9.
9
MRI/TRUS fusion software-based targeted biopsy: the new standard of care?
Minerva Urol Nefrol. 2015 Sep;67(3):233-46. Epub 2015 May 27.
10
Posterior subcapsular prostate cancer: identification with mpMRI and MRI/TRUS fusion-guided biopsy.
Abdom Imaging. 2015 Oct;40(7):2557-65. doi: 10.1007/s00261-015-0426-8.
Zotero 插件